NCT03349710 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03349710
Title	Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer
Recruitment	Completed
Gender	both
Phase	Phase III
Variant Requirements	No
Sponsors	Bristol-Myers Squibb
Indications	hypopharynx cancer oral squamous cell carcinoma head and neck squamous cell carcinoma oropharynx cancer laryngeal squamous cell carcinoma
Therapies	Cetuximab Cisplatin Cetuximab + Nivolumab Cisplatin + Nivolumab
Age Groups:	adult \| senior
Covered Countries	USA \| TUR \| POL \| ITA \| FRA \| ESP

NCT03349710
Clinical Trial Detail